Holly Williams

3 weeks ago | independent.co.uk | Holly Williams

Jim Mullen has stepped down immediately ‘by mutual agreement’The chief executive of Mirror and Express newspaper publisher Reach has quit after nearly six years. Jim Mullen has stepped down immediately “by mutual agreement.”Mr Mullen, who used to be CEO at Ladbrokes, is leaving to head up horse-racing company The Jockey Club. Reach chief revenue officer Piers North has been appointed to replace him, the company said.

4 weeks ago | independent.co.uk | Holly Williams

The housebuilder saw pre-tax profits plunge 64% to £104.9 million in a ‘challenging’ 2024. Holly WilliamsHousebuilder Vistry has seen profits tumble after cost reporting issues in its Southern division, but is hoping for a boost from the Government’s £2 billion affordable homes pledge.

1 month ago | independent.co.uk | Holly Williams

The online electricals retailer expects profits to rise by about 30% in 2024-25. From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

1 month ago | aberdeenlive.news | Holly Williams |Ruaraidh Britton

Troubled engineering firm John Wood Group has given its Dubai-based suitor Sidara more time to come up with a firm offer. Aberdeen-headquartered Wood Group said Sidara – a privately held network of engineering and design companies run from the United Arab Emirates – now has until April 17 to make an offer or walk away under City takeover rules. The previous so-called “put up or shut up” deadline had been set for after market close on Monday.

1 month ago | independent.co.uk | Holly Williams

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of British pharmaceutical group GSK and US rival Pfizer. Holly WilliamsUS pharmaceutical firm Pfizer has sold off its remaining stake in Sensodyne and Panadol maker Haleon for around £2.5 billion. Haleon has agreed to buy back 44 million shares from Pfizer for £3.85 a share – totalling about £170 million – as part of the deal, with the remaining 618 million shares being sold to institutional investors.